Howdy Timeline of events: Y2014-2018 : R&D, products Ready &...

Howdy

Timeline of events:

Y2014-2018 : R&D, products Ready & Refined for production

Y2018, April-May-June : Multiple Regulatory events, multiple Re'ratings expected, #$

Y2018, May : Factory, 1000'000 units/yr, Ready to go

Y2018 - 2023 :
Multiple binding MOUs = conditional sale-agreements (#$),
5 years in advance
Y1=$100m,
Ready to go


What more do we want?
Cheers
Aimo
G

~


#$ ,
32503513



Key things that need to happen in the near term.

"We believe GMV has very substantial commercial potential, especially if the company can manufacture and assemble the Prizma and GMP in volumes that allow the company to service multiple large markets (US, Europe, China, India) simultaneously.

In order for that to happen, several steps will need to be taken in the near term:

1.FDA approval for the GMP in the US (expected 2HY18)
2. FDA approval for OTC sales of thePrizma in the US (expected Q2 or Q3 2018) to allow GMV to directly sell the Prizma online.
3.CFDA approval in China for both the Prizma and the GMP (expected 2Q18).
4.CFDA approval in China for GMV’s manufacturing and assembly facilities (expected 2Q18).
...

Point number 4 is particularly important given that GMV will be using its Chinese facilities to ramp
up assembly of both the Prizma and the GMP. "


p18
https://gmedinnovations.com/wp-content/uploads/2018/04/20180417_GMV-The-Strong-Pulse-of-mHealth.pdf

=

TMTAnlytics, v1 , v2 , 32482603

~